搜索结果181-190 的 1607 / treatment resistant depression
Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
The purpose of this study is to demonstrate non-inferior 12-month overall survival of patients with GlioblastomA (GBM) treated with dose escalated ...
... treating patients with meningiomas that may have gotten bigger or grew back after treatment. Vismodegib and FAK inhibitor GSK2256098 may stop the growth of ...
The purpose of this study is to to determine the individual treatment effect of somatostatin and whether duration of antibiotic therapy coupled with octreotide ...
Mayo Clinic study reveals proton beam therapy may shorten breast cancer treatment ... Mayo Clinic researchers identify drug resistance factors for advanced ...
... treatment (including surgery, radiation and/or adjuvant or neoadjuvant chemotherapy). Cohort 2 includes (1) muCALR+ primary MF, and (2) muCALR+ secondary MF ...
The purpose of the Pediatric Proton Consortium Registry (PPCR) is to enroll children who have been treated with proton radiation in the United States in ...
Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM). Scottsdale/Phoenix, Ariz. This is a phase ...
这种罕见的血管疾病可能会导致呼吸问题、面部疼痛和持续流鼻涕。药物有助于缓解。
Jyoti Bhagia, M.D.. Psychiatrist. Rochester, MN. 擅长领域:. Obesity, Attention-deficit/hyperactivity disorder in children, Teen depression, Mood disorder, ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊,和我们一起进行尖端研究和医护,共同推动医学的改变。